Research Articles
The Silent Battle Within: Mapping Hepatitis B in Eritrea
A groundbreaking study reveals the hidden landscape of hepatitis B viral infection affecting thousands in Eritrea, with insights into serological profiles and treatment outcomes.
When First-Line Drugs Fail: The Combination Therapy Fighting Hepatitis B Resistance
Discover how combining adefovir dipivoxil with lamivudine created an effective strategy against lamivudine-resistant hepatitis B, with insights from meta-analysis and clinical trials.
Revolutionizing Hepatitis B Research: The 3D Spheroid Breakthrough
Explore how 3D spheroid technology is transforming hepatitis B research with enhanced liver models that support long-term HBV infection studies.
Entecavir for Lamivudine-Resistant Hepatitis B: A Scientific Breakthrough
Meta-analysis comparing entecavir monotherapy vs combination therapy for lamivudine-resistant hepatitis B patients
The Silent Victory: How Iran's Hepatitis B Vaccination Program Protects Its Children
Exploring the success of Iran's hepatitis B vaccination program in protecting children and reducing infection rates in Gorgan and beyond.
The Hidden Threat: When "Cured" Hepatitis B Awakens in Cancer Patients
Understanding hepatitis B virus reactivation in non-Hodgkin's lymphoma patients with resolved HBV infection and its clinical implications.
The Double Trouble Liver: How PEG-IFNα-2a Fights Hepatitis B Complicated by Fatty Liver
Exploring the efficacy of pegylated interferon alpha-2a in treating chronic hepatitis B patients with coexisting fatty liver disease (MASLD).
Beyond the Antiviral: Rebooting the Body's Army to Cure Hepatitis B
Explore how scientists are shifting from antiviral drugs to immune system therapies for a functional cure for chronic Hepatitis B virus infection.
The Silent Stowaway: Unmasking Occult Hepatitis B in Hemodialysis Patients
Exploring the hidden threat of occult hepatitis B infection in hemodialysis patients, its detection challenges, and modern clinical strategies.
The Great Medication Dilemma: What Happens When Hepatitis B Patients Stop Treatment?
Exploring the risks and benefits of stopping nucleos(t)ide analog therapy for chronic hepatitis B patients, including immune reawakening potential and predictive biomarkers.